{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:24:11Z","timestamp":1766748251017,"version":"build-2065373602"},"reference-count":181,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.path.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T19:09:26Z","timestamp":1564081766000},"page":"745-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["EBV\u2013Associated Lymphoproliferative Disorders"],"prefix":"10.1016","volume":"12","author":[{"given":"Sherif A.","family":"Rezk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2005-07-2702","article-title":"Epstein-Barr virus: the impact of scientific advances on clinical practice","volume":"107","author":"Williams","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.path.2019.03.002_bib2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders","volume":"38","author":"Rezk","year":"2007","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"10.1016\/j.path.2019.03.002_bib4","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.path.2019.03.002_bib5","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V79.10.2520.bloodjournal79102520","article-title":"Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue","volume":"79","author":"Niedobitek","year":"1992","journal-title":"Blood"},{"issue":"Pt 1","key":"10.1016\/j.path.2019.03.002_bib6","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.path.2019.03.002_bib7","series-title":"Lymph nodes","first-page":"39","article-title":"Acute infectious mononucleosis","author":"Weiss","year":"2008"},{"key":"10.1016\/j.path.2019.03.002_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2018.05.020","article-title":"Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update","volume":"79","author":"Rezk","year":"2018","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1309\/B3WH-QWBY-YV61-CE46","article-title":"The molecular characterization of fatal infectious mononucleosis","volume":"117","author":"Wick","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib10","series-title":"WHO classification of hematopoietic and lymphoid tissues","first-page":"355","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative disease of childhood","author":"Quintanilla-Martinez","year":"2017"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11899-015-0292-z","article-title":"The Epstein-Barr virus (EBV) in T cell and NK cell lymphomas: time for a reassessment","volume":"10","author":"Gru","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.3800369","article-title":"Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils","volume":"18","author":"Hudnall","year":"2005","journal-title":"Mod Pathol"},{"issue":"21","key":"10.1016\/j.path.2019.03.002_bib13","doi-asserted-by":"crossref","first-page":"11139","DOI":"10.1128\/JVI.76.21.11139-11142.2002","article-title":"Evidence for early infection of nonneoplastic natural killer cells\u00a0by Epstein-Barr virus","volume":"76","author":"Trempat","year":"2002","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcp\/aqw213","article-title":"T- and NK-cell lymphomas and systemic lymphoproliferative disorders and the immunodeficiency setting: 2015 SH\/EAHP workshop report-part 4","volume":"147","author":"Gratzinger","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib16","series-title":"Hematopathology","first-page":"957","article-title":"Non-neoplastic histiocytic proliferations of lymph nodes and bone marrow","author":"Rezk","year":"2017"},{"issue":"9","key":"10.1016\/j.path.2019.03.002_bib17","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semdp.2012.08.009","article-title":"Viral-associated lymphoid proliferations","volume":"30","author":"Pittaluga","year":"2013","journal-title":"Semin Diagn Pathol"},{"issue":"22","key":"10.1016\/j.path.2019.03.002_bib19","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"issue":"2 Pt 1","key":"10.1016\/j.path.2019.03.002_bib22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0190-9622(00)90127-0","article-title":"Hydroa vacciniforme: a clinical and follow-up study of 17 cases","volume":"42","author":"Gupta","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","article-title":"The association of latent Epstein-Barr virus infection with hydroa vacciniforme","volume":"140","author":"Iwatsuki","year":"1999","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.path.2019.03.002_bib25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archderm.139.12.1601","article-title":"CD4+\u00a0T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis","volume":"139","author":"Asada","year":"2003","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.0022-202X.2005.23915.x","article-title":"Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites","volume":"125","author":"Asada","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-positive B-cell proliferations of varied malignant potential: 2015 SH\/EAHP workshop report-part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bjh.12743","article-title":"Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer","volume":"165","author":"Sadasivam","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3899\/jrheum.130270","article-title":"A\u00a0clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.path.2019.03.002_bib31","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"307","article-title":"EBV-positive mucocutaneous ulcer","author":"Gaulard","year":"2017"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J\u00a0Exp Med"},{"issue":"Suppl 1","key":"10.1016\/j.path.2019.03.002_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/13.S1.11","article-title":"Biology of Hodgkin's lymphoma","volume":"13","author":"Kuppers","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2019.03.002_bib34","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"424","article-title":"Hodgkin lymphoma, introduction","author":"Stein","year":"2017"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/his.13085","article-title":"Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma","volume":"70","author":"Chang","year":"2017","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ijc.2910460405","article-title":"High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients","volume":"46","author":"Uccini","year":"1990","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/mp.53.5.262","article-title":"Hodgkin's disease and the Epstein-Barr virus","volume":"53","author":"Flavell","year":"2000","journal-title":"Mol Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib38","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","article-title":"Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor","volume":"17","author":"Kilger","year":"1998","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.path.2019.03.002_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","article-title":"Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death","volume":"65","author":"Henderson","year":"1991","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.onc.1202351","article-title":"Molecular mechanisms of constitutive NF-kappaB\/Rel activation in Hodgkin\/Reed-Sternberg cells","volume":"18","author":"Krappmann","year":"1999","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/blood.V95.1.294","article-title":"Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype","volume":"95","author":"Kim","year":"2000","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.path.2019.03.002_bib43","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1200\/JCO.2008.20.5138","article-title":"Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients","volume":"27","author":"Diepstra","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2019.03.002_bib44","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"262","article-title":"Burkitt lymphoma","author":"Leoncini","year":"2017"},{"issue":"10","key":"10.1016\/j.path.2019.03.002_bib45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B\u00a0cells under influence: transformation of B cells by Epstein-Barr virus","volume":"3","author":"Kuppers","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.path.2019.03.002_bib46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.path.2019.03.002_bib47","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"issue":"7418","key":"10.1016\/j.path.2019.03.002_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.path.2019.03.002_bib49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A\u00a0recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.002_bib50","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"334","article-title":"Burkitt-like lymphoma with 11q aberration","author":"Leoncini","year":"2017"},{"issue":"24","key":"10.1016\/j.path.2019.03.002_bib51","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1093\/emboj\/19.24.6742","article-title":"Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction","volume":"19","author":"Kitagawa","year":"2000","journal-title":"EMBO J"},{"issue":"10","key":"10.1016\/j.path.2019.03.002_bib52","doi-asserted-by":"crossref","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct viral and mutational spectrum of endemic Burkitt lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semcancer.2009.10.002","article-title":"Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus","volume":"19","author":"Chene","year":"2009","journal-title":"Semin Cancer Biol"},{"issue":"40","key":"10.1016\/j.path.2019.03.002_bib54","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib55","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood-2013-11-537076","article-title":"Not like a wrecking ball: EBV fine-tunes MYC lymphomagenesis","volume":"123","author":"Dittmer","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.path.2019.03.002_bib56","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0b013e3181fd8781","article-title":"Lymphomatoid granulomatosis: insights gained over 4 decades","volume":"34","author":"Katzenstein","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib57","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"312","article-title":"Lymphomatoid granulomatosis","author":"Pittaluga","year":"2017"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000328","article-title":"Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations","volume":"39","author":"Song","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09031936.98.12010102","article-title":"Lymphomatoid granulomatosis--a report on four cases: evidence for B phenotype of the tumoral cells","volume":"12","author":"Taniere","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.path.2019.03.002_bib60","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"222","article-title":"B-cell prolymphocytic leukemia","author":"Campo","year":"2017"},{"issue":"15","key":"10.1016\/j.path.2019.03.002_bib61","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2019.03.002_bib62","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","article-title":"Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases","volume":"37","author":"Martinez","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2019.03.002_bib64","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","article-title":"Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib65","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1073\/pnas.90.1.352","article-title":"Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in\u00a0vivo is associated with reduced expression of viral latent genes","volume":"90","author":"Rochford","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.path.2019.03.002_bib66","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/1097-0142(19871015)60:8<1771::AID-CNCR2820600817>3.0.CO;2-2","article-title":"Non-Hodgkin's lymphoma of the pleural cavity developing from\u00a0long-standing pyothorax","volume":"60","author":"Iuchi","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.path.2019.03.002_bib67","series-title":"World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus, and heart","first-page":"137","article-title":"Lymphomas","author":"Banks","year":"2004"},{"key":"10.1016\/j.path.2019.03.002_bib68","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"245","article-title":"DLBCL associated with chronic inflammation","author":"Chan","year":"2008"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib69","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/01.pas.0000157747.10967.f4","article-title":"Metallic implant-associated lymphoma: a distinct subgroup of large B-cell lymphoma related to pyothorax-associated lymphoma?","volume":"29","author":"Cheuk","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<287::AID-PATH932>3.0.CO;2-Q","article-title":"Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation","volume":"183","author":"Copie-Bergman","year":"1997","journal-title":"J\u00a0Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib71","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.carpath.2012.08.002","article-title":"Incidental Epstein-Barr virus associated atypical lymphoid proliferation arising in a left atrial myxoma: a case of long survival without any postsurgical treatment and review of the literature","volume":"22","author":"Bartoloni","year":"2013","journal-title":"Cardiovasc Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.03.002_bib72","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/PAS.0b013e3182515fb5","article-title":"Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation?","volume":"36","author":"Boroumand","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.03.002_bib73","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/PAS.0b013e31825d53b5","article-title":"Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomas","volume":"36","author":"Gruver","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAS.0b013e3181ce9128","article-title":"Epstein-Barr virus-associated diffuse large B-cell lymphoma arising on cardiac prostheses","volume":"34","author":"Miller","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib75","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"309","article-title":"Diffuse large B-cell lymphoma associated with chronic inflammation","author":"Chan","year":"2017"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib76","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PAS.0000000000000775","article-title":"Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation","volume":"41","author":"Boyer","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3960\/jslrt.46.5","article-title":"Pyothorax-associated lymphoma","volume":"46","author":"Aozasa","year":"2006","journal-title":"J\u00a0Clin Exp Hematop"},{"issue":"Suppl 3","key":"10.1016\/j.path.2019.03.002_bib78","first-page":"525","article-title":"Role of an immunosuppressive cytokine, interleukin-10, in the development of pyothorax-associated lymphoma","volume":"11","author":"Kanno","year":"1997","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.carpath.2014.08.007","article-title":"Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus?","volume":"24","author":"Aguilar","year":"2015","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib80","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib81","article-title":"EBV positive diffuse large B-cell lymphoma of the elderly","volume":"vol. 243-245","author":"Nakamura","year":"2008"},{"issue":"7","key":"10.1016\/j.path.2019.03.002_bib82","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.002_bib83","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"304","article-title":"EBV-positive diffuse large B-cell lymphoma, not otherwise specified (NOS)","author":"Nakamura","year":"2017"},{"issue":"Suppl 1","key":"10.1016\/j.path.2019.03.002_bib84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/ijlh.12650","article-title":"2016 WHO classification update-what's new in lymphoid neoplasms","volume":"39","author":"Hsi","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.path.2019.03.002_bib85","series-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","first-page":"342","article-title":"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma","author":"Jaffe","year":"2016"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.46.1","article-title":"Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review","volume":"46","author":"Shimoyama","year":"2006","journal-title":"J\u00a0Clin Exp Hematop"},{"issue":"7","key":"10.1016\/j.path.2019.03.002_bib87","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2015-06-648097","article-title":"The expanding spectrum of EBV+ lymphomas","volume":"126","author":"Said","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib88","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/his.13428","article-title":"Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder","volume":"72","author":"Wang","year":"2018","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib89","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/PAS.0000000000000128","article-title":"HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma","volume":"38","author":"Crane","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib90","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/modpathol.2009.36","article-title":"HHV8-positive, EBV-positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma","volume":"22","author":"Ferry","year":"2009","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib91","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4132\/jptm.2016.09.30","article-title":"Human herpes virus 8\/Epstein-Barr virus-copositive, plasmablastic microlymphoma arising in multicentric Castleman's disease of an immunocompetent patient","volume":"51","author":"Lee","year":"2017","journal-title":"J\u00a0Pathol Transl Med"},{"key":"10.1016\/j.path.2019.03.002_bib92","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"323","article-title":"Primary effusion lymphoma","author":"Said","year":"2017"},{"issue":"9","key":"10.1016\/j.path.2019.03.002_bib93","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood.V96.9.3279.h8003279_3279_3281","article-title":"Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients","volume":"96","author":"Luppi","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib94","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<288::AID-PATH419>3.0.CO;2-F","article-title":"Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient","volume":"189","author":"Cobo","year":"1999","journal-title":"J\u00a0Pathol"},{"issue":"23","key":"10.1016\/j.path.2019.03.002_bib95","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1182\/blood-2013-07-515882","article-title":"HHV-8-positive but EBV-negative primary effusion lymphoma","volume":"122","author":"Song","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib96","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1309\/AJCPHZ3CHO4HUWET","article-title":"Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature","volume":"140","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib97","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JVI.79.2.1244-1251.2005","article-title":"Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association","volume":"79","author":"Fan","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"17","key":"10.1016\/j.path.2019.03.002_bib98","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1158\/0008-5472.CAN-08-0627","article-title":"EBV is necessary for proliferation of dually infected primary effusion lymphoma cells","volume":"68","author":"Mack","year":"2008","journal-title":"Cancer Res"},{"issue":"Pt 6","key":"10.1016\/j.path.2019.03.002_bib99","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1099\/0022-1317-79-6-1445","article-title":"Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line","volume":"79","author":"Szekely","year":"1998","journal-title":"J\u00a0Gen Virol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2003-05-1710","article-title":"Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression","volume":"103","author":"Trivedi","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2019.03.002_bib101","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1128\/JVI.02743-06","article-title":"Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas","volume":"81","author":"Xu","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"9","key":"10.1016\/j.path.2019.03.002_bib102","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2002-02-0487","article-title":"KSHV- and EBV-associated germinotropic lymphoproliferative disorder","volume":"100","author":"Du","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib103","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/PAS.0000000000000823","article-title":"KSHV-associated and EBV-associated germinotropic lymphoproliferative disorder: new findings and review of the literature","volume":"41","author":"Bhavsar","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib104","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/modpathol.2016.233","article-title":"HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma","volume":"30","author":"Gonzalez-Farre","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib105","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"241","article-title":"Plasma cell neoplasms","author":"McKenna","year":"2017"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib106","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/ajt.12234","article-title":"Plasma cell neoplasms in US solid organ transplant recipients","volume":"13","author":"Engels","year":"2013","journal-title":"Am J Transplant"},{"issue":"17","key":"10.1016\/j.path.2019.03.002_bib107","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1182\/blood-2012-12-470393","article-title":"Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy","volume":"122","author":"Ouedraogo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.002_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.09.002","article-title":"Solitary plasmacytoma associated with Epstein-Barr virus: a clinicopathologic, cytogenetic study and literature review","volume":"27","author":"Yan","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib109","first-page":"503","article-title":"Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus","volume":"8","author":"Aguilera","year":"1995","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0974-7796.134286","article-title":"Solitary extramedullary plasmacytoma of the penis","volume":"6","author":"Scarberry","year":"2014","journal-title":"Urol Ann"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000011831","article-title":"Plasmacytoma of the gastrointestinal tract in Korea: higher incidence than in Japan and Epstein-Barr virus association","volume":"55","author":"Tomita","year":"1998","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib112","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1309\/27H8XJH31F3GUNAT","article-title":"Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV","volume":"128","author":"Chang","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib113","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2009.04.025","article-title":"Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells","volume":"284","author":"Anastasiadou","year":"2009","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib114","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in\u00a0vivo","volume":"79","author":"Laichalk","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.10094","article-title":"Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease\/lymphoma: clinicopathologic, serologic, and molecular analysis","volume":"70","author":"Mitarnun","year":"2002","journal-title":"Am J Hematol"},{"issue":"33","key":"10.1016\/j.path.2019.03.002_bib116","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein-Barr virus and oncogenesis: from latent genes to tumours","volume":"22","author":"Young","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.path.2019.03.002_bib117","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"407","article-title":"Angioimmunoblastic T-cell lymphoma and other nodal lymphomas of T-follicular helper cell origin","author":"Dogan","year":"2017"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib118","first-page":"392","article-title":"Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"122","author":"Weiss","year":"1986","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.path.2019.03.002_bib119","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.5858\/2006-130-1707-ATLWSE","article-title":"Angioimmunoblastic T-cell lymphoma with supervening Epstein-Barr virus-associated large B-cell lymphoma","volume":"130","author":"Hawley","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.path.2019.03.002_bib120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.194.7.927","article-title":"Survival and clonal expansion of mutating \"forbidden\" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected b cells in angioimmunoblastic t cell lymphoma","volume":"194","author":"Brauninger","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.path.2019.03.002_bib121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.2003.tb06046.x","article-title":"Somatic hypermutation and B cell receptor selection in normal and transformed human B cells","volume":"987","author":"Kuppers","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib122","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib123","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib124","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hon.2900080505","article-title":"Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type","volume":"8","author":"Ho","year":"1990","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.path.2019.03.002_bib126","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"368","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2017"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib127","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2141.2001.02887.x","article-title":"Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells","volume":"114","author":"Noguchi","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib128","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3892\/or.2015.4305","article-title":"LMP1 promotes nasal NK\/T-cell lymphoma cell function by eIF4E via NF-kappaB pathway","volume":"34","author":"Sun","year":"2015","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib129","doi-asserted-by":"crossref","first-page":"e0174136","DOI":"10.1371\/journal.pone.0174136","article-title":"EBV induces persistent NF-kappaB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells","volume":"12","author":"Takada","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.path.2019.03.002_bib130","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/ijc.22139","article-title":"Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3","volume":"119","author":"Takahara","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.002_bib132","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"353","article-title":"Aggressive NK-cell leukaemia","author":"Chan","year":"2017"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib133","first-page":"3423","article-title":"Six cases of aggressive natural killer-cell leukemia in a Chinese population","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"10.1016\/j.path.2019.03.002_bib134","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/modpathol.2017.37","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: a clinical and pathological study from a single institution","volume":"30","author":"Gao","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib135","first-page":"77","article-title":"Natural killer cell neoplasms","volume":"3","author":"Chan","year":"1998","journal-title":"Anat Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0037-1963(03)00136-7","article-title":"Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas\/leukemias","volume":"40","author":"Cheung","year":"2003","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib137","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.pap.0000151318.34752.80","article-title":"The pathology of NK-cell lymphomas and leukemias","volume":"12","author":"Nava","year":"2005","journal-title":"Adv Anat Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.03.002_bib138","first-page":"713","article-title":"Extranodal NK\/T-cell lymphoma, nasal type extensively involving the bone marrow","volume":"4","author":"Rezk","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib139","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2014.12.030","article-title":"Epstein-Barr virus-associated lymphomas","volume":"42","author":"Grywalska","year":"2015","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib141","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3892\/ol.2012.754","article-title":"Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: report of a case with review of the literature","volume":"4","author":"Yoshii","year":"2012","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib142","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib143","first-page":"1165","article-title":"Clinicopathological states of Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults","volume":"24","author":"Suzuki","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.path.2019.03.002_bib144","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"403","article-title":"Peripheral T-cell lymphoma, NOS","author":"Pileri","year":"2017"},{"issue":"12","key":"10.1016\/j.path.2019.03.002_bib145","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.path.2019.03.002_bib146","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1158\/0008-5472.CAN-04-0733","article-title":"Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.path.2019.03.002_bib147","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199805143382003","article-title":"Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients","volume":"338","author":"Liebowitz","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.path.2019.03.002_bib148","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","article-title":"Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study","volume":"108","author":"Dupuis","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib149","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0145-2126(02)00266-7","article-title":"High tumor necrosis factor-alpha levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease\/lymphoma","volume":"27","author":"Mori","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.path.2019.03.002_bib150","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"449","article-title":"Lymphomas associated with HIV infection","author":"Said","year":"2017"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib151","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.semdp.2017.04.003","article-title":"Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point","volume":"34","author":"Linke-Serinsoz","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib152","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib153","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib154","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1470-2045(03)00957-4","article-title":"Emerging pathways in the development of AIDS-related lymphomas","volume":"4","author":"Carbone","year":"2003","journal-title":"Lancet Oncol"},{"issue":"3\u20134","key":"10.1016\/j.path.2019.03.002_bib156","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jemt.20230","article-title":"AIDS-related non-Hodgkin's lymphomas","volume":"68","author":"Krause","year":"2005","journal-title":"Microsc Res Tech"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib157","first-page":"390","article-title":"The epidemiology of acquired immunodeficiency syndrome malignancies","volume":"27","author":"Goedert","year":"2000","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib158","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/neup.12276","article-title":"Primary central nervous system lymphomas and related diseases: pathological characteristics and discussion of the differential diagnosis","volume":"36","author":"Sugita","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.path.2019.03.002_bib159","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","article-title":"Post-transplant lymphoproliferative disorders","volume":"56","author":"Gottschalk","year":"2005","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5500\/wjt.v6.i3.505","article-title":"Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders","volume":"6","author":"Morscio","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.path.2019.03.002_bib161","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"453","article-title":"Post-transplant lymphoproliferative disorders","author":"Swerdlow","year":"2016"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib162","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0b013e3182190999","article-title":"EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?","volume":"35","author":"Gibson","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib163","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib164","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hon.751","article-title":"Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis","volume":"23","author":"Capello","year":"2005","journal-title":"Hematol Oncol"},{"issue":"9353","key":"10.1016\/j.path.2019.03.002_bib165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(03)12271-4","article-title":"Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma","volume":"361","author":"Timms","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.path.2019.03.002_bib166","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/modpathol.2014.68","article-title":"In\u00a0vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications","volume":"27","author":"Gonzalez-Farre","year":"2014","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.path.2019.03.002_bib167","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jcp.50.11.911","article-title":"Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas","volume":"50","author":"Brink","year":"1997","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib168","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1309\/AJCPQYYE04AVGVYI","article-title":"Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation","volume":"138","author":"Nelson","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2019.03.002_bib169","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"462","article-title":"Other iatrogenic immunodeficiency-associated lymphoproliferative disorders","author":"Gaulard","year":"2017"},{"issue":"6","key":"10.1016\/j.path.2019.03.002_bib170","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib171","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.path.2019.03.002_bib172","first-page":"1748","article-title":"Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature","volume":"7","author":"Nakanishi","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.002_bib173","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2007-09-111534","article-title":"Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression","volume":"111","author":"Wondergem","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib174","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ajg.2012.334","article-title":"T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: results of the REFURBISH study","volume":"108","author":"Deepak","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.path.2019.03.002_bib176","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.path.2019.03.002_bib177","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.path.2019.03.002_bib178","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/his.12627","article-title":"Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders","volume":"67","author":"Yamada","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.03.002_bib179","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"444","article-title":"Lymphoproliferative diseases associated with primary immune disorders","author":"van Krieken","year":"2017"},{"issue":"Suppl","key":"10.1016\/j.path.2019.03.002_bib180","first-page":"S122","article-title":"Lymphoproliferative disease associated with immune deficiency in children","volume":"122","author":"van Krieken","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.002_bib181","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/14737159.3.5.549","article-title":"Pathogenesis and diagnosis of X-linked lymphoproliferative disease","volume":"3","author":"Gilmour","year":"2003","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:59Z","timestamp":1761748859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":181,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1875918119300194"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.03.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EBV\u2013Associated Lymphoproliferative Disorders","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}